» Articles » PMID: 35445187

The Genomic Landscape of Pediatric Renal Cell Carcinomas

Abstract

Pediatric renal cell carcinomas (RCC) differ from their adult counterparts not only in histologic subtypes but also in clinical characteristics and outcome. However, the underlying biology is still largely unclear. For this reason, we performed whole-exome and transcriptome sequencing analyses on a cohort of 25 pediatric RCC patients with various histologic subtypes, including 10 MiT family translocation (MiT) and 10 papillary RCCs. In this cohort of pediatric RCC, we find only limited genomic overlap with adult RCC, even within the same histologic subtype. Recurrent somatic mutations in genes not previously reported in RCC were detected, such as in , , , . Our papillary pediatric RCCs, which represent the largest cohort to date with comprehensive molecular profiling in this age group, appeared as a distinct genomic subtype differing in terms of gene mutations and gene expression patterns not only from MiT-RCC but also from their adult counterparts.

Citing Articles

Targeted therapies in children with renal cell carcinoma (RCC): An International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG)-related retrospective descriptive study.

Sprokkerieft J, van der Beek J, Spreafico F, Selle B, Thebaud E, Chowdhury T Cancer Med. 2024; 13(1):e6782.

PMID: 39102694 PMC: 10807685. DOI: 10.1002/cam4.6782.


Exploring the genetic control of sweat gland characteristics in beef cattle for enhanced heat tolerance.

Hernandez A, Zayas G, Rodriguez E, Sarlo Davila K, Rafiq F, Nunez A J Anim Sci Biotechnol. 2024; 15(1):66.

PMID: 38715151 PMC: 11077762. DOI: 10.1186/s40104-024-01025-4.


Whole-exome sequencing of rectal neuroendocrine tumors.

Li Y, Guo Y, Cheng Z, Tian C, Chen Y, Chen R Endocr Relat Cancer. 2023; 30(9).

PMID: 36645718 PMC: 10450454. DOI: 10.1530/ERC-22-0257.

References
1.
Linehan W, Spellman P, Ricketts C, Creighton C, Fei S, Davis C . Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2015; 374(2):135-45. PMC: 4775252. DOI: 10.1056/NEJMoa1505917. View

2.
Williamson S, Gill A, Argani P, Chen Y, Egevad L, Kristiansen G . Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer. Am J Surg Pathol. 2020; 44(7):e47-e65. PMC: 7289677. DOI: 10.1097/PAS.0000000000001476. View

3.
Lavacchi D, Pellegrini E, Palmieri V, Doni L, Mela M, Di Maida F . Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective. Int J Mol Sci. 2020; 21(13). PMC: 7369721. DOI: 10.3390/ijms21134691. View

4.
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N . The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25(16):2078-9. PMC: 2723002. DOI: 10.1093/bioinformatics/btp352. View

5.
Scribner J, Brown J, Son T, Chiechi M, Li P, Sharma S . Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer. Mol Cancer Ther. 2020; 19(11):2235-2244. DOI: 10.1158/1535-7163.MCT-20-0116. View